Trends in adrenalectomy: a recent national review
- PMID: 20336320
- DOI: 10.1007/s00464-010-0996-z
Trends in adrenalectomy: a recent national review
Abstract
Background: Adrenalectomy remains the definitive therapy for most adrenal neoplasms. Introduced in the 1990s, laparoscopic adrenalectomy is reported to have lower associated morbidity and mortality. This study aimed to evaluate national adrenalectomy trends, including major postoperative complications and perioperative mortality.
Methods: The Nationwide Inpatient Sample was queried to identify all adrenalectomies performed during 1998-2006. Univariate and multivariate logistic regression were performed, with adjustments for patient age, sex, comorbidities, indication, year of surgery, laparoscopy, hospital teaching status, and hospital volume. Annual incidence, major in-hospital postoperative complications, and in-hospital mortality were evaluated.
Results: Using weighted national estimate, 40,363 patients with a mean age of 54 years were identified. Men made up 40% of these patients, and 77% of the patients were white. The majority of adrenalectomies (83%) were performed for benign disease. The annual volume of adrenalectomies increased from 3,241 in 1998 to 5,323 in 2006 (p < 0.0001, trend analysis). The overall in-hospital mortality was 1.1%, with no significant change. Advanced age (< 45 years as the referent; ≥ 65 years: adjusted odds ratio [AOR], 4.10; 95%; confidence Interval [CI], 1.66-10.10) and patient comorbidities (Charlson score 0 as the referent; Charlson score ≥ 2: AOR, 4.33; 96% CI, 2.34-8.02) were independent predictors of in-hospital mortality. Indication, year, hospital teaching status, and hospital volume did not independently affect perioperative mortality. Major postoperative in-hospital complications occurred in 7.2% of the cohort, with a significant increasing trend (1998-2000 [5.9%] vs 2004-2006 [8.1%]; p < 0.0001, trend analysis). Patient comorbidities (Charlson score 0 as the referent; Charlson score ≥ 2: AOR, 4.77; 95% CI, 3.71-6.14), recent year of surgery (1998-2000 as the referent; 2004-2006: AOR, 1.40; 95% CI, 1.09-1.78), and benign disease (malignant disease as the referent; benign disease: AOR, 1.98; 95% CI, 1.55-2.53) were predictive of major postoperative complications at multivariable analyses, whereas laparoscopy was protective (no laparoscopy as the referent; laparoscopy: AOR, 0.62; 95% CI, 0.47-0.82).
Conclusion: Adrenalectomy is increasingly performed nationwide for both benign and malignant indications. In this study, whereas perioperative mortality remained low, major postoperative complications increased significantly.
Similar articles
-
Is same-day discharge associated with increased 30-day postoperative complications and readmissions in patients undergoing laparoscopic adrenalectomy?Surgery. 2021 Feb;169(2):289-297. doi: 10.1016/j.surg.2020.08.018. Epub 2020 Sep 30. Surgery. 2021. PMID: 33008614
-
Trends in utilization of adrenalectomy in the United States: have indications changed?World J Surg. 2004 Nov;28(11):1169-75. doi: 10.1007/s00268-004-7619-6. World J Surg. 2004. PMID: 15490057
-
Trends in adrenalectomy rates, indications, and physician volume: A statewide analysis of 1816 adrenalectomies.Surgery. 2007 Dec;142(6):1011-21; discussion 1011-21. doi: 10.1016/j.surg.2007.09.024. Surgery. 2007. PMID: 18063089
-
High perioperative morbidity and mortality in patients with malignant nonfunctional adrenal tumors.J Surg Res. 2017 Nov;219:259-265. doi: 10.1016/j.jss.2017.05.116. Epub 2017 Jul 6. J Surg Res. 2017. PMID: 29078892
-
Volume-outcome relationship in adrenal surgery: A review of existing literature.Best Pract Res Clin Endocrinol Metab. 2019 Oct;33(5):101296. doi: 10.1016/j.beem.2019.101296. Epub 2019 Jul 12. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31331729 Review.
Cited by
-
Comparison of adrenalectomy with conservative treatment on mild autonomous cortisol secretion: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2024 May 13;15:1374711. doi: 10.3389/fendo.2024.1374711. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38808111 Free PMC article.
-
Pheochromocytoma: a changing perspective and current concepts.Ther Adv Endocrinol Metab. 2023 Oct 29;14:20420188231207544. doi: 10.1177/20420188231207544. eCollection 2023. Ther Adv Endocrinol Metab. 2023. PMID: 37916027 Free PMC article. Review.
-
Impact of Current Technology in Laparoscopic Adrenalectomy: 20 Years of Experience in the Treatment of 254 Consecutive Clinical Cases.J Clin Med. 2023 Jun 29;12(13):4384. doi: 10.3390/jcm12134384. J Clin Med. 2023. PMID: 37445419 Free PMC article. Review.
-
Management of Patients with Treatment of Pheochromocytoma: A Critical Appraisal.Cancers (Basel). 2022 Aug 9;14(16):3845. doi: 10.3390/cancers14163845. Cancers (Basel). 2022. PMID: 36010839 Free PMC article. Review.
-
Minimally invasive adrenalectomy for large pheochromocytoma: not recommendable yet? Results from a single institution case series.Langenbecks Arch Surg. 2022 Feb;407(1):277-283. doi: 10.1007/s00423-021-02312-8. Epub 2021 Sep 1. Langenbecks Arch Surg. 2022. PMID: 34468864 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
